Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
MediPharm Labs (MEDIF) Stock Price & Analysis
404 Followers
MEDIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $0.08
Previous Close$0.05
Volume28.11K
Average Volume (3M)83.87K
Market Cap
$22.10M
Enterprise Value$10.77M
Total Cash (Recent Filing)C$17.98M
Total Debt (Recent Filing)C$2.29M
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Aug 12, 2024EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding404,048,948
10 Day Avg. Volume62,197
30 Day Avg. Volume83,874
Standard Deviation0.18
R-Squared0.09
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)0.66
Price to Cash Flow (P/CF)5.50
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MediPharm Labs News
PremiumCompany Announcements
MediPharm Labs Shareholders Approve Board and Auditor
PremiumCompany Announcements
MediPharm Labs Secures Novel Cannabis Technology
PremiumCompany Announcements
MediPharm Labs Sees Strong Growth and OptimismPremiumPress Releases
MediPharm Labs Reports First Quarter Results
PremiumPre-Earnings
Is MEDIF a Buy, Before Earnings?
PremiumCompany Announcements
MediPharm Labs to Unveil Q1 2024 FinancialsOptions Prices
Currently, No data available
---
Ownership Overview
20.58% Insiders
0.00% Mutual Funds
0.89% Other Institutional Investors
78.53% Public Companies and
Individual Investors
MEDIF FAQ
What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was $0.04 and its highest was $0.08 in the past 12 months.
What is MediPharm Labs’s market cap?
Currently, no data Available
When is MediPharm Labs’s upcoming earnings report date?
MediPharm Labs’s upcoming earnings report date is Aug 12, 2024 which is in 40 days.
How were MediPharm Labs’s earnings last quarter?
MediPharm Labs released its earnings results on May 15, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of -$0.006 by -$0.001.
Is MediPharm Labs overvalued?
According to Wall Street analysts MediPharm Labs’s price is currently Overvalued.
Does MediPharm Labs pay dividends?
MediPharm Labs does not currently pay dividends.
What is MediPharm Labs’s EPS estimate?
MediPharm Labs’s EPS estimate is >-$0.01.
How many shares outstanding does MediPharm Labs have?
MediPharm Labs has 404,818,100 shares outstanding.
What happened to MediPharm Labs’s price movement after its last earnings report?
MediPharm Labs reported an EPS of -$0.007 in its last earnings report, missing expectations of -$0.006. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MediPharm Labs?
Currently, no hedge funds are holding shares in MEDIF
---
MediPharm Labs Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.55%
12-Months-Change
Fundamentals
Return on Equity
-26.39%
Trailing 12-Months
Asset Growth
-1.29%
Trailing 12-Months
Company Description
MediPharm Labs
MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.
---
MEDIF Earnings Call
Q1 2024
0:00 / 0:00
---
Technical Analysis
---